Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

4DMEDICAL LIMITED Director's Dealing 2021

Apr 11, 2021

64259_rns_2021-04-11_678caa1e-a418-4bf0-8154-2540bc15c68d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity 4DMedical Limited
ABN 31 161 684 831

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Bruce Rathie
Date of last notice 14 August 2020 (Appendix 3X)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Katrat Investments Pty Ltd as trustee for
Rathie Family Trust

director of Katrat Investments Pty
Ltd

beneficiary of Rathie Family Trust
Rathie Super Pty Ltd as trustee for
Rathie Superannuation Fund

director of Rathie Super Pty Ltd

beneficiary
of
Rathie
Superannuation Fund
Date of change 7 April 2021
No. of securities held prior to change 300,000 ordinary shares held by Katrat
Investments Pty Ltd as trustee for Rathie
Family Trust
200,000 ordinary shares held by Rathie
Super Pty Ltd as trustee for Rathie
Superannuation Fund
Class Fully paid ordinary shares
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired Katrat Investments Pty Ltd as trustee for
Rathie Family Trust: 4,819 shares
Rathie Super Pty Ltd as trustee for
Rathie
Superannuation
Fund:
4,819
shares
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Katrat Investments Pty Ltd as trustee for
Rathie Family Trust: $7,469.45
Rathie Super Pty Ltd as trustee for
Rathie Superannuation Fund: $7,469.45
No. of securities held after change Katrat Investments Pty Ltd as trustee for
Rathie Family Trust: 304,819 fully paid
ordinary shares
Rathie Super Pty Ltd as trustee for
Rathie Superannuation Fund: 204,819
fully paid ordinary shares
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation
in buy-back
Issue of securities under share purchase
plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts
detailed above traded during a+closed period
where prior written clearance was required?
No
If so, was prior written clearance provided to allow
the trade to proceed during this period?
N/A
If prior written clearance was provided, on what
date was this provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3